 |
||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Welch Allyn Expands Patient Monitor Capabilities with Masimo Pulse Oximetry Technology Vital Signs Monitor 300 Series latest Welch Allyn monitor to offer Masimo SET SpO2 Beaverton, Ore., and Irvine, Calif., February 9, 2006 - In an effort to continue to meet the challenges caregivers in multiple environments face every day, Welch Allyn, a leading manufacturer of frontline medical products and solutions, announced the availability of Masimo SET® pulse oximetry (SpO2) in the Vital Signs Monitor 300 Series automated vital signs monitor. The offering marks the latest collaboration between the two companies in a partnership that applies Masimo pulse oximetry technology across a range of Welch Allyn patient monitoring solutions. "We strive to offer frontline caregivers solutions that maximize their flexibility without changing the way they work," said Doug Linquest, Welch Allyn executive vice president, acute care and Asia. "Adding the option of Masimo SET SpO2 to the Vital Signs Monitor 300 Series partners the gold standard pulse oximetry technology with one of the most simple, versatile and affordable vital signs monitors out there today." The Vital Signs Monitor 300 Series is a fully-featured patient monitor that provides simple, automated vital signs measurement before, during, and after medical procedures. It allows caregivers to either spot-check or continuously monitor patients' blood pressure, temperature, heart rate and pulse oximetry from a single device. "The Vital Signs Monitor 300 Series is a great product and with it Welch Allyn has satisfied a previously unmet need," said Joe Kiani, Masimo Chief Executive Officer. "We're delighted to have the opportunity to expand our partnership with Welch Allyn, and extend clinician and patient access to Masimo pulse oximetry farther than ever before." Masimo SET (Signal Extraction Technology) pulse oximetry is a highly advanced method of monitoring the oxygenation of a patient's blood. Masimo technology has been clinically proven to read through motion and low perfusion at a high level of accuracy, with certain studies showing improved patient outcomes. Welch Allyn offers Masimo SET pulse oximetry in a variety of other products, including the new Spot Vital Signs LXi spot-check device, Propaq CS and Propaq Encore continuous vital signs monitors and the Micropaq wireless telemetry monitor. "As the trend continues away from hospital-based inpatient procedures to more outpatient procedures and more acute procedures, caregivers need flexible continuous monitoring solutions," Linquest said. "Masimo technology makes the Vital Signs Monitor 300 Series better equipped to meet that need." About Welch Allyn Welch Allyn, Inc. was founded in 1915 and is today a leading manufacturer of innovative medical diagnostic and therapeutic devices, cardiac defibrillators, patient monitoring systems, and miniature precision lamps. Headquartered in Skaneateles Falls, New York, USA, Welch Allyn employs more than 2,100 people and has numerous manufacturing, sales, and distribution facilities located throughout the world. Additional information on Welch Allyn and its products may be found at www.welchallyn.com. |
||||
 |
 |
 |
 |